Navigation Links
HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral
Date:12/17/2008

SAN JOSE, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") announced that it has filed a Comprehensive Patent Application with the U.S. Patent and Trademark Office for the use of an innovative and previously undeveloped compound with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well-being and social attraction.

"We are very excited about the potential of this naturally-occurring compound that we have labeled ER 303. Just inhaling very small quantities resulted in enhanced feelings of confidence, relaxation, affection, warmth, satisfaction and sensuality, in both men and women," a spokesperson indicated. Before the Company perfected the reproduction of this compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island.

"The Patent Application covers use in a wide range of products that may be enhanced and differentiated by the addition of ER 303, including those in the cosmetics and fragrance, personal care, environmental and household fields. Before filing for patent protection, the Company and its scientists have worked for more than eight years from the initial identification, reproducing the compound in the laboratory, conducting psychological and physiological scientific studies with men and women volunteers, and developing a manufacturing process for broad-scale production," the spokesperson also noted. The Company indicated that it is in the process of establishing http://www.ER303.com as its website which will contain additional information about the ER 303 technology and its potential applications for consumer product companies.

The Company has previously been granted broad-based worldwide patents for
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AMERIGROUP Files Shelf Registration Statement
2. PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers
3. Bally Total Fitness Files for Chapter 11 Bankruptcy Protection
4. Aduromed Files Patent Application to Cover Proprietary New Standard for Containerized, Turnkey Solution
5. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
6. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
7. VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
8. State Fund Files an 8.9 Percent Premium Increase for 2009
9. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
10. Genesis Pharmaceuticals Files Counter Claims
11. Mary Hall, CEO of iHealthSpot, Inc., is Awarded Membership Into Fort Lauderdale City Limits "Profiles of Excellence"

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...recognize signs of depression , , SATURD...the holiday season can trigger melancholy as they ...issues or worry about money problems, according to...rcome the seasonal blues, the AGS Foundation for H...t out and socialize or invite family and friends o...
(Date:11/27/2009)...wire-FirstCall/ -- The Gymboree Corporation (Nasda...will present at the NASDAQ OMX 23rd Investor Progr...ndon, England, on Wednesday, December 2, 2009, at ...t of The Gymboree Corporation,s presentation over ...lick on "Our Company" at the bottom of the page, g...
(Date:11/27/2009)...icles may reduce future disease burden, researcher...s) -- Encouraging city dwellers to walk and bicycl...ublic health benefits than increased used of low-e..., The study compared the projected health effects ...ios for London, England, and Delhi, India: busine...
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009)...olybdate (TM) has been shown in studies to be effe...e caused by an overload of copper, and certain met...however, is known about how the drug works at the ...rn University researchers now has provided an inva... bound to copper-loaded metallochaperones. The dru...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
..., Dec. 3, 2008 Joined by actress Maggie,Gyllenhaa...tionwide search for,five child Holiday Ambassadors...an event in New York City. The Duracell Holiday A...spread the joy of powering,up a gift for the first...
...., Dec. 3 Decision Resources, one of the,world,s ...armaceutical and,healthcare issues, finds that the...se in China is extremely low and will remain low t...eimer,s disease,population in China in 2012, less ...
... NextAdvisor.com has created a free g...ch to dieting. , San Fran....com , the trusted, independent source for compari...useful advice for those embarking on a new diet pl...
... Around 80 HBA, MBF and Mutual Commun...ir feet where their mouths were on Sunday to promo... charity in the inaugural HBA Great Australian Run... put their feet where their mouths were on Sunday ...
...Dec. 3 AGA Medical Corporation announced,today th...enne) approval for,its AMPLATZER(R) Cardiac Plug (...vasive solution for closing cardiac structures not...t addition to the interventional tools we have for...
...ec. 3, 2008 Scientists at UT Southwestern Medical...tein interferon plays a key role in "teaching" the...s of the same virus. , The findings, available on...therapies. , Typically, when a person is infecte...
Other Medicine News:Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 2Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 3Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:NextAdvisor.com Launches "Lose the Weight this Year: A Common Sense Dieter's Guide" 2Health News:HBA People Walk the Talk for Better Health in the HBA Great Australian Run 2Health News:AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug 2Health News:Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report 2
(Date:11/25/2009)... 25 Cempra Pharmaceuticals Inc. to...t and chief executive officer, will present at the...at 8:50 a.m. EST, December 1, 2009, at The New Yor...ll provide an overview of the company,s two leadin...f drug-resistant pathogens including MRSA. ,, ...
(Date:11/25/2009)...25 ChemoCentryx, Inc., announced...mpany,s PROTECT-1 (the Prospective Randomized Oral...raficet-EN(TM) (CCX282-B) in patients with moderat...efficacy with a favorable safety and tolerability ...cal efficacy in the reduction of disease severity ...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Vermillion, Inc. (VRML) (P... Plan of Reorganization and Disclosure Statement t...nkruptcy Court for the District of Delaware. A hea...ent is presently scheduled for December 8, 2009, w...heduled for January 7, 2010. ,, The Plan calls...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3
... Congresswoman Debbie,Wasserman Schultz will prese... the U.S. Department of Defense to support spinal ...y Professor Jeffery Alan Plunkett - a leader in,sp...ity President Monsignor,Franklyn M. Casale will pr...cience programs - including financial aid opportun...
... 21 Qualia Clinical Services, a highly,regarded d...Logos,Technologies electronic data capture (EDC) s...n its Phase I clinical facility in Omaha,Nebraska....ity with ALPHADAS will,enable us to provide our Ph...ime access to critical data while conducting state...
Other Medicine Technology:Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials 2
DErrico Perforator Drill and Enlarging Burr
Cushing Perforator Drill
Doro J-Arm Retractor System
Spoon End Periosteal
Medicine Products: